WHAT WE STAND FOR
Imagine a healthcare system where decisions are informed by personalized care profiles and predictive analytics, improving the health of all patients.
Meet our founder
Nassib Chamoun
We build data analytics that deliver insights—quickly and transparently—to solve real problems for patients, populations, and ACOs.
Creating a new life
As a teenager living in Beirut, Nassib experienced the horror of a civil war that divided and destroyed the once-beautiful city. He narrowly escaped execution by militants and lived with the constant danger of sniper crossfire, and the terror of relentless shelling. He was able to leave the violence behind by enrolling in Northeastern University and then went on to graduate studies at Boston University and the Harvard School of Public Health.
During this time, Nassib met two men who would become his life-long friends and mentors: the late Bernard Lown, MD, pioneering cardiologist, humanitarian, and Nobel Peace Prize winner, and the late Charlie Zraket, former CEO of Mitre Corp. Both nurtured his love of data-driven problem solving and inspired him to focus his life’s work on finding insights to complex questions that will have a positive impact on society.
“By providing Bloomberg-like insights and analytics, HDAI has more potential to drive improvement in the healthcare system to the benefit of patients, providers, and payors than any project I’ve worked on in my four decades as a venture capital investor.”
Edwin Kania,
Co-Founder
“HDAI is a place where kindness matters.”
Carola Endicott,
Customer Engagement and Marketing
“I have the deepest respect for clinical expertise and judgement, and I know that nothing we do should ever replace that. Enhance, augment, but never replace.”
Phil Devlin,
COO
“We’re building something special here — an incredibly talented, diverse, and inclusive team where employees feel appreciated and welcomed.”
Margie Ahearn,
VP HR
Team
Headquartered near Boston, we have a 20-year history of building and deploying predictive models to advance our mission of improving the health of populations and individuals.
Team
Headquartered near Boston, we have a 20-year history of building and deploying predictive models to advance our mission of improving the health of populations and individuals.
Board of Directors
We are backed by investors and advisors who share our vision and keep us focused on our mission to extract value from health data and revolutionize its use for the good of society. Our board members come from finance, medical device, health IT, research and academia, and they are committed to helping us get it right.
John J. O’Connor
Chairman
John O’Connor is the former vice chairman of services for PricewaterhouseCoopers. He also serves on several corporate boards. He received a BA from Suffolk University and an MBA from the Amos Tuck School at Dartmouth College. He graduated from the Harvard Business School’s Leadership in Professional Service Firms program.
Edwin M. Kania, Jr
Co-Founder
Edwin Kania is the co-founder of Flagship Pioneering, a leading life sciences venture firm. He has 35 years of experience in the venture capital industry. Mr. Kania has worked with entrepreneurs and invested in over 100 companies valued at over $10 billion. He received a BS in physics from Dartmouth College and an MBA from Harvard Business School.
Kenneth A. Froot
Co-Founder
Kenneth Froot is a founding partner of FDO Partners, LLC, State Street Associates and MKT MediaStats. Mr. Froot is a professor at Harvard University. He received a BA from Stanford University and a Ph.D. from the University of California at Berkeley. His research on various financial topics has been widely published.
Marcus Traill
Director
Marcus Traill began his career as an analyst at Bank of New Zealand and Owens Group prior to joining the McPike Global Family Office (MGFO). At QuantRes, part of the MGFO, he has played key roles in the trading of various quantitative strategies and was responsible for managing the operations of the group. As co-head of Private Investments he oversaw the MGFO private investment strategy. He is now a Founding Partner at Altered Capital, a venture capital and reinvestment stage fund manager focused on private growth companies pursuing strategies in technology, healthcare, and financials. He remains a close advisor to MGFO and serves as an Investor Director at Starling Bank, a UK regulated digital bank.
Transform the way you care for your patients
